-
EP3608337
European procedure
Extract from the Register of European Patents
EP About this file: EP3608337
| EP3608337 - BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 21.02.2025 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 15.03.2024 | ||
| Former | Grant of patent is intended Status updated on 09.11.2023 | ||
| Former | Examination is in progress Status updated on 17.03.2023 | ||
| Former | Request for examination was made Status updated on 14.08.2020 | ||
| Former | The application has been published Status updated on 10.01.2020 | Most recent event Tooltip | 21.02.2025 | No opposition filed within time limit | published on 26.03.2025 [2025/13] | Applicant(s) | For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [2020/07] | Inventor(s) | 01 /
AST, Oliver c/o Roche Glycart AG Wagistrasse 10 8952 Schlieren / CH | 02 /
BACAC, Marina c/o Roche Glycart AG Wagistrasse 10 8952 Schlieren / CH | 03 /
IMHOF-JUNG, Sabine c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | 04 /
NEUMANN (formally JAEGER), Christiane c/o Roche Glycart AG Wagistrasse 10 8952 Schlieren / CH | 05 /
KLEIN, Christian c/o Roche Glycart AG Wagistrasse 10 8952 Schlieren / CH | 06 /
KLOSTERMANN, Stefan c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | 07 /
MOLHOJ, Michael c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | 08 /
REGULA, Joerg Thomas c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | 09 /
SCHAEFER, Wolfgang c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | 10 /
UMAÑA, Pablo c/o Roche Glycart AG Wagistrasse 10 8952 Schlieren / CH | [2024/16] |
| Former [2020/07] | 01 /
AST, Oliver c/o Roche Glycart AG Wagistrasse 10 8952 Schlieren / CH | ||
| 02 /
BACAC, Marina c/o Roche Glycart AG Wagistrasse 10 8952 Schlieren / CH | |||
| 03 /
IMHOF-JUNG, Sabine c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | |||
| 04 /
NEUMANN (formally JAEGER), Christiane c/o Roche Glycart AG Wagistrasse 10 8952 Schlieren / CH | |||
| 05 /
KLEIN, Christian c/o Roche Glycart AG Wagistrasse 10 8952 Schlieren / CH | |||
| 06 /
KLOSTERMANN, Stefan c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | |||
| 07 /
MOLHOJ, Michael c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | |||
| 08 /
REGULA, Joerg Thomas c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | |||
| 09 /
SCHAEFER, Wolfgang c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | |||
| 10 /
UMAÑA, Pablo c/o Roche Glycart AG Wagistrasse 10 8952 Schlieren / CH | Representative(s) | Winkler, Thomas F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124 4070 Basel / CH | [2020/07] | Application number, filing date | 19172443.4 | 03.08.2015 | [2020/07] | Priority number, date | EP20140179764 | 04.08.2014 Original published format: EP 14179764 | EP20150170866 | 05.06.2015 Original published format: EP 15170866 | [2020/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3608337 | Date: | 12.02.2020 | Language: | EN | [2020/07] | Type: | B1 Patent specification | No.: | EP3608337 | Date: | 17.04.2024 | Language: | EN | [2024/16] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.01.2020 | Classification | IPC: | C07K16/28, C07K16/30, C07K16/32, A61P35/00 | [2023/49] | CPC: |
C07K16/2809 (EP,CN,IL,KR,US);
A61P35/00 (EP,KR);
C07K16/2878 (EP,CN,KR,US);
C07K16/2887 (EP,CN,IL,KR,US);
C07K16/3053 (EP,CN,US);
C07K16/32 (EP,CN,KR,US);
A61K2039/505 (KR);
C07K2317/14 (EP,CN,US);
C07K2317/21 (EP,CN,US);
C07K2317/31 (EP,CN,IL,KR,US);
C07K2317/33 (EP,CN,US);
C07K2317/51 (EP,CN,US);
C07K2317/515 (EP,CN,US);
C07K2317/526 (EP,CN,US);
C07K2317/54 (EP,CN,US);
C07K2317/55 (EP,CN,KR,US);
C07K2317/64 (EP,CN,IL,US);
C07K2317/66 (EP,CN,KR,US);
C07K2317/71 (KR);
C07K2317/732 (EP,CN,KR,US);
C07K2317/92 (EP,CN,KR,US);
C07K2317/94 (EP,CN,US)
(-)
|
| Former IPC [2020/07] | C07K16/28, C07K16/30, C07K16/32 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/38] |
| Former [2020/07] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Validation states | MA | 12.08.2020 | Title | German: | BISPEZIFISCHE ANTIGENBINDENDE MOLEKÜLE ZUR T-ZELLEN-AKTIVIERUNG | [2020/07] | English: | BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES | [2020/07] | French: | MOLÉCULES BISPÉCIFIQUES DE LIAISON À L'ANTIGÈNE ACTIVANT DES LYMPHOCYTES T | [2020/07] | Examination procedure | 12.08.2020 | Amendment by applicant (claims and/or description) | 12.08.2020 | Examination requested [2020/38] | 12.08.2020 | Date on which the examining division has become responsible | 16.03.2023 | Despatch of a communication from the examining division (Time limit: M04) | 17.07.2023 | Reply to a communication from the examining division | 05.09.2023 | Despatch of a communication from the examining division (Time limit: M01) | 14.09.2023 | Reply to a communication from the examining division | 10.11.2023 | Communication of intention to grant the patent | 07.03.2024 | Fee for grant paid | 07.03.2024 | Fee for publishing/printing paid | 07.03.2024 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP15742329.4 / EP3177643 | Opposition(s) | 20.01.2025 | No opposition filed within time limit [2025/13] | Fees paid | Renewal fee | 03.09.2019 | Renewal fee patent year 03 | 03.09.2019 | Renewal fee patent year 04 | 08.08.2019 | Renewal fee patent year 05 | 17.08.2020 | Renewal fee patent year 06 | 09.08.2021 | Renewal fee patent year 07 | 09.08.2022 | Renewal fee patent year 08 | 22.08.2023 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 17.04.2024 | [2025/10] | Documents cited: | Search | [Y]WO2009089004 (AMGEN INC [US], et al); | [Y]EP2647707 (CHUGAI PHARMACEUTICAL CO LTD [JP]); | [Y]WO2014081955 (AMGEN INC [US]); | [T]WO2015150447 (HOFFMANN LA ROCHE [CH], et al); | by applicant | US4186567 | EP0404097 | WO9301161 | WO9316185 | US5500362 | WO9627011 | US5565332 | US5571894 | US5587458 | US5731168 | US5821337 | WO9850431 | US5869046 | US5959177 | US5969108 | US6040498 | US6054297 | US6248516 | US6417429 | US6420548 | US6737056 | WO2005100402 | US6982321 | WO2006029879 | US7087409 | WO2006082515 | US7125978 | WO2007110205 | EP1870459 | WO2007147901 | US7332581 | US7527791 | WO2009080251 | WO2009080252 | WO2009080253 | WO2009080254 | WO2009089004 | US7695936 | WO2010129304 | WO2011090754 | WO2011090762 | WO2011143545 | WO2012058768 | WO2012130831 | WO2013096291 | WO2013157954 | WO2013157953 | WO2015EP57165 |